|Bid||5.45 x 0|
|Ask||6.00 x 0|
|Day's Range||5.70 - 5.80|
|52 Week Range||2.02 - 7.60|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens on Thursday, August 20, 2020.
Aiming to provide better health management services to lung cancer patients, "Cloud Enabled Lung Cancer Care by Great Doctors" was officially launched in Shanghai on July 25, 2020. The lung cancer patient care program (the "Program"), spearheaded by China Primary Health Care Foundation and co-hosted by Beijing Life Oasis Public Service Center, attracted the participation of 20 domestic and world-renowned lung cancer pharmaceutical and medical equipment companies. The Program offers diagnostic and treatment services including science popularization, medication guides, online consultation, follow-up consultation and clinic visitation support for lung cancer patients via a full life-cycle doctor-patient interaction platform. The platform is to be established and operated by 111, Inc. ("111"), a leading online healthcare company in China.
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]